FSCN1 and colorectal cancer: Following this line, in 2020, Alburquerque-Gonzalez et al. showed that imipramine attenuated cell migration and invasion of colorectal cancer cells by inhibition of fascin [71], a key protein in actin bundling that plays a causative role in tumor invasion and is overexpressed in different cancer types with poor prognosis [117].